Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

BUPIVACAINE AND EPINEP

Active
SPE2DP-26-T-4389Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

3380 STURTEVANT ST STE 2, SAN DIEGO, CA, 92136, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4389.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts

Full Description

Show more
BUPIVACAINE AND EPINEPHRINE INJECTION
BUPIVACAINE <(>&<)> EPINEPHRINE INJECTION
.
0.500 PCT W/V BUPIVACAINE HCL AND 0.005 MG
EPINEPHRINE/ML (1:200,000) 1.8 ML CARTRIDGE, 50'S
.
UNIT OF ISSUE: (U/I): CN (CAN)
.
CONTROLLED ROOM TEMP OR REQUIRES CONTROLLED ROOM TEMP
STORAGE BETWEEN 15 AND 30 DEG C.
.
SHELF LIFE IS 18 MONTHS. A SHELF LIFE OF 15 MONTHS
SHELF LIFE SHALL REMAIN AT THE TIME OF DELIVERY TO THE
FIRST GOV'T ACTIVITY.
.
MARK IN ACCORDANCE WITH MMS No. 1B 30 March 2017
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
SPE2DP-26-T-4389
SECTION B
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 CN = 50 EA
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
.
FSSB 11/14/2019
RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
DENTAL HEALTH PRODUCTS INCORPORATED 02QR5 P/N 120-99184 CARESTREAM DENTAL LLC 47R32 P/N 99184 PATTERSON DENTAL 5XLW0 P/N 095-2796 HENRY SCHEIN, INC. 0NUS8 P/N 1316823 BENCO DENTAL SUPPLY CO. 1V865 P/N 5235-587
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017681406 0001 CN 2.000
NSN/MATERIAL:6505011893973
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129.
SPE2DP-26-T-4389
SECTION B
PR: 7017681406 PRLI: 0001 CONT’D
The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R70026
USS MIGUEL KEITH (ESB-5)
3380 STURTEVANT ST STE 2
SAN DIEGO CA 92136
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R70026
USS MIGUEL KEITH (ESB-5)
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
M/F: (TCN) R700266208HM20
RDD: 777
PROJ: EK5 TP 2
SUPP ADD: YNHM01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A41 DIST: 9B ADV: 2A FC: N7
Need Ship Date:00/00/0000 Original Required Delivery Date:08/03/2026
SPE2DP-26-T-4389 NSN/Part Number: 6505-01-189-3973 Quantity: 2 CN Purchase Request: 7017681406QTY: 2 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
ERYTHROMYCIN OPHTHALMI
Solicitation # SPE2DP-26-T-4394
ERYTHROMYCIN OPHTHALMIC OINTMENT USP is a sterile, topical ointment containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, intended for ophthalmic use only. Each unit is packaged as a single-dose tube containing 3.5 grams of ointment, with 24 tubes per package, defined as the unit of issue. The product must have a minimum of 31 months of remaining shelf life upon receipt by the first government activity, as its total shelf life is 36 months and is non-extendable. Storage requirements mandate controlled room temperature between 15°C and 30°C (59°F–86°F), with protection from excessive heat and freezing. All packaging and labeling must strictly adhere to Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and must comply with DLA’s Master List of Technical and Quality Requirements. The ointment is regulated by the FDA and must be marked and shipped in accordance with commercial packaging standards, specifically ASTM D3951 if not classified as hazardous under FED-STD-313; however, DLA requirements take precedence over all other standards. Each shipment must be delivered FOB destination within five days, using the fastest traceable means, excluding parcel post, to the specified delivery point at Fort Lewis, WA. The product is identified by NSN 6505-01-189-7090, with a single purchase order quantity of one package, and the manufacturer is PADAGIS US LLC under NDC 00574-4024-39.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LAC
Solicitation # SPE2DP-26-T-4395
RINGER'S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4395 with a total order of 7 packing groups, equivalent to 84 individual units. The product is manufactured by B. Braun Medical Inc. with NDC 00264-7750-00 and is subject to FDA regulation. Packaging must comply strictly with Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and must ensure protection from damage and breakage during transit. Each unit must be sealed and packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost to the specified destination, which is FPO AP 96675. The item has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C), with brief exposure up to 40°C permitted. Packaging must adhere to DLA’s RP001 requirements and the latest DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. No hazard classification applies under FED-STD-313, so commercial packaging per ASTM D3951 is acceptable but subordinate to DLA standards. Delivery is required within 20 days of contract award, with zero quantity variance allowed, and inspection and acceptance occur at the delivery point. The unit of issue is packing group (PG), with each PG containing 12 units. All markings, labeling, and palletization must conform to specified DLA and federal standards, and shipping instructions must follow DLAD Proc Note C19 and C20. The solicitation closed on August 5, 2026, with an original required delivery date of August 3, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DOXYCYCLINE HYCLATE
Solicitation # SPE2DP-26-T-4150
Doxycycline Hyclate Tablets, USP equivalent to 100 mg of doxycycline, are supplied in film-coated form as unit packs of 100 tablets per bottle, with the unit of issue defined as a bottle (BT). The contract mandates strict adherence to Medical Marking Standard No. 1A dated February 4, 2013, superseding all references to MIL-STD-129, and requires each unit to be sealed in a container that protects against damage and breakage, while exterior shipping containers must ensure safe, cost-effective delivery by common carriers to the designated destination. All packaging and labeling must conform to DLA’s Technical and Quality Requirements, with hazardous material handling governed by FED-STD-313 and ASTM D3951 only if the item is not classified as hazardous, and DLA’s standards take precedence over commercial standards. The product has a non-extendable shelf life of 36 months and must be stored at controlled room temperature between 20 to 25°C (68 to 77°F), protected from light and moisture. The item is regulated by the FDA, and buyers must submit a referral through EBS to confirm bidder and manufacturer details, including NDC62135-0626-01. The total quantity ordered is eight bottles (8 BT), with delivery required within 20 days FOB destination to Fort Bragg, North Carolina, using traceable shipping methods and prohibiting parcel post. The contract prohibits any variance in quantity, and inspection and acceptance occur at the destination. The shipment must be palletized per RP001 requirements and marked with the specified government identifiers, including the NSN 6505016003042 and project code TP 3, with the supplier identified as CHARTWELL RX LLC.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 4 days
View Details